You are here

  • Home
  • Archive
  • Volume 13, Issue Suppl 1
  • SHOULD CA125 RESPONSE CRITERIA BE PREFERRED TO WHO CRITERIA IN THE MONITORING OF SECOND-LINE CHEMOTHERAPY (SLC) OF EPITHELIAL OVARIAN CARCINOMA (EOC)?

Alerts

Article menu
Download PDFPDF
ABSTRACTS: PLENARY SESSIONS: Session 4 – Ovary and Vulva
SHOULD CA125 RESPONSE CRITERIA BE PREFERRED TO WHO CRITERIA IN THE MONITORING OF SECOND-LINE CHEMOTHERAPY (SLC) OF EPITHELIAL OVARIAN CARCINOMA (EOC)?
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address